Scientists at the University of California, San Francisco, have made a genetically engineered virus that turns the deadly brain tumor into a biofactory, pumping out a highly inflammatory protein. That protein should help expose the tumor and recruit immune cells to destroy it.

The treatment looks promising in mice, according to a paper published online in Nature Communications last month. Now, a startup called Kopra Bio has raised $9.1 million in seed funding to test the experimental treatment in humans, the company told Endpoints News in an exclusive interview.

Massive congratulations to the Kopra Bio team on their recent funding announcement. 👏  Manish Aghi, Noriyuki Kasahara, Alexander Haddad, and Sara Collins to help spin this critical brain cancer therapy out of the lab.

Endpoints News paywall.

Tech Times no paywall